MCM Group

News

New computational method for drug discovery

11. July 2018

HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover …

Read more

Accelerated reactions in condensed bio-matter?

19. June 2018

HITS researcher Dr. Kashif Sadiq explores ribonucleoprotein granules, a condensed form of bio-matter found inside cells. He investigates whether the rate …

Read more

EuroNeurotrophin project starts

1. March 2018

14 Early Stage Researchers to be trained in a European training network for the discovery of small molecule neurotrophin mimetics as candidate …

Read more

A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

15. January 2018

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The …

Read more

Announcing Fourth Biological Diffusion and Brownian Dynamics Brainstorm Meeting (BDBDB 4)

11. October 2017

Biological Diffusion and Brownian Dynamics Brainstorm 4 (BDBDB4) will, like the previous meetings (the last was BDBDB3), provide a forum for intensive …

Read more

New TRAPP webserver for studying TRAnsient Pockets in Proteins

29. May 2017

Many drugs exert their therapeutic effects by binding in cavities or pockets on specific target protein macromolecules. The binding pockets on …

Read more

Young Researcher´s award goes to HITS doctoral student

17. May 2017

Mehmet Ali Öztürk, PhD student at HITS and at the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (…

Read more

On the front cover: Multiexpert Platform for the Identification of Hits Targeting Parasitic Enzymes

29. March 2017

In the New Medicines for Trypanosomatidic Infections (NMTRypI) project funded by the EU and completed in January 2017, in which 13 partners …

Read more

Switch to the German homepage or stay on this page